Swiss court reaffirms recommended retail price ruling

Switzerland’s highest court has once again ruled that recommended price-list publications are anticompetitive, ordering a lower court to confirm sanctions against Eli Lilly and Bayer for restricting competition for their respective erectile dysfunction drugs.

Unlock unlimited access to all Global Competition Review content